baber/WOPTO huggingface dataset:
Patent AT-E328616-T1 (AT)
Inventor: WILLITSCH FRIEDRICH-DIPL-ING
IPC: A61L9/16
Filed: 1999-06-18
Granted: 2006-06-15
Abstract: To clean and sterilize the exhaust air from rubbish dumps and/or rubbish sorting plants, it is passed through a heated section of an industrial plant. The air is heated to a min. temp. where any germs or toxic matter are destroyed by heat. The exhaust air is passed through a heat exchanger and a drying drum for the rubbish at the industrial plant, where the plant delivers heat to the heat exchanger. The exhaust air can be passed through a cooler at the industrial plant. The exhaust air can be used as combustion air at a burner or furnace of the industrial plant. An Independent claim is included for an assembly of rubbish dumps and/or rubbish sorting stations (1,3,4,23), which are linked (29,30) to the section (21) of an industrial plant (22) which delivers heat. The rubbish exhaust air is heated to a min. temp. where any germs or toxic matter are destroyed in the exhaust air. Preferred Features: The heating section (21) of the industrial plant (22) is a furnace or a cooler. An extractor fan assembly (32,33) is in the link between the stations (1,3,4,23) and the heated section (21) of the industrial plant (22), to draw out the exhaust air by suction. The cooler (21) has at least two chambers (25a-25c) for the exhaust air to be passed selectively through one or more chambers, taken selectively from one or more different stations (1,3,4,23). A heat exchanger (7) takes emerging air from the section (21) of the industrial plant (22) on one side, and the exhaust air from the rubbish station (1,3) on the other side. A drying drum (4) for the rubbish is in the exhaust air passage (29,34) between the heat exchanger (7) and the section (21) of the industrial plant (22). The drying drum (4) has two successive sections (4a,4b) in the axial flow line of the drum (4), which rotate in opposite directions. The exhaust air channel (34) opens into the following section (4a) in the direction of rubbish flow. The assembly has a mesh sifting drum (12) and an end sorting drum (17), with a connecting link (30) to the section (21) of the industrial plant (22), and pref. through a dust winnower (20). The cooler (21) is at the kiln of a cement clinker production plant (22).
Patent AT-E216286-T1 (AT)
Inventor: ANDERS HORST
IPC: F23G5/033
Filed: 1999-02-01
Granted: 2002-05-15
Abstract: The invention relates to a method for treating waste materials in which a fraction having a high calorific value and a predetermined maximum particle diameter is obtained by means of mechanical, thermal and biological treatment. The fraction can either be utilized as replacement fuel in energy intensive processes or is burned in a refuse incinerator, whereby the free-emerging energy can be utilized by coupling the energy to an energy intensive process, or is gasified. The resulting gas can subsequently be used in an energetic or material manner such as, for example, for energy substitution in power plants and cement factories, for producing methanol or can be utilized as a reduction means in steel plants.
Patent AT-E270278-T1 (AT)
Inventor: HATZELMANN ARMIN
IPC: A61K31/502
Filed: 1999-03-04
Granted: 2004-07-15
Abstract: The compounds of formula (I) in which R1, R2, R3, R4, R5, X and Y have the meanings as given in the description are novel effective bronchial therapeutica.
Patent AT-E223171-T1 (AT)
Inventor: LANGEGGER JOSEF
IPC: A47C23/06
Filed: 1999-05-06
Granted: 2002-09-15
Abstract: The invention relates to a support for an upholstered article (16), comprising two tubes (7, 8) filled with a medium and positioned on a substructure (1). A cover (17) extends between transverse bars (4) resting on the tubes (7, 8) and the upholstered articles (16). The tubes (7, 8) are positioned in tube sleeves (13, 14) which are connected to the cover (17). On each tube (7, 8) a looped tape (21, 22) is arranged which passes underneath the transverse bars (15) and between them is joined to the cover (17).
Patent AT-E474055-T1 (AT)
Inventor: CARLIN NILS
IPC: C12N1/21
Filed: 1999-05-21
Granted: 2010-07-15
Abstract: A method of producing a thy A<SUP>-</SUP>strain of vibrio cholerae comprising the step of site-directed mutagenesis in the V. cholerae chromosome at the locus of the thy A gene SEQ ID NO: 1 of FIG. 1 , is described. Particularly, a Delta thy A strain of Vibrio cholerae lacking the functionality of the thy A is disclosed. This strain may comprise one or several episomal autonomously replicating DNA elements, such as plasmids, having an optionally foreign, e.g. E. coli, functional thy A gene that enables the strain to grow in the absence of thymine in the growth medium, and optionally having a structural gene encoding a homologous or heterologous protein. Further, proteins encoded by a structural thy A gene and the 5'-flanking region are described as SEQ ID NO: 4 of FIG. 4 and SEQ ID NO: 5 of FIG. 5 , respectively. Additionally, a vaccine comprising a Vibrio cholerae Delta thy A strain of the invention or a thy A<SUP>-</SUP>strain of Vibrio cholerae produced by the method of the invention is disclosed.
Patent AT-E312638-T1 (AT)
Inventor: ABRAMS ANDREW L
IPC: A61J3/00
Filed: 1999-06-14
Granted: 2005-12-15
Abstract: A dry powder inhaler comprises a first chamber in which a dry powder may be deaggregated by a vibrator and separated by size, and a second chamber in which the size-separated deaggregated powder may be picked up by an air stream and carried for introduction into a patient. Electronic circuitry (48) is included for controlling dosing. In another embodiment of the invention, a fluid sensor is employed to activate and control various components of an inhalation device. The fluid sensor includes an acoustic element (208), such as a microphone, positioned within said inhalation device to detect fluid within the device and output signals representative of the frequency and/or amplitude of the fluid. These signals control and activate an electrostatic plate (226) and/or a high frequency vibrator (228). In yet another embodiment of the invention, electrostatic phototechnology is used to package microgram quantities of fine powders such as drugs in discrete capsule and tablet form. An electrostatic "image" (325A) having a given size and charge density is exposed to ionised drug powder to attract a known amount of drug to the image. The resultant drug "image" (326A) is then transferred (330) to an open ended capsule (329), a partially formed table (360) or edible wafer (384) or belt (390). The capsule is then sealed, e.g. by capping, or the tablet finished.
Patent AT-E265993-T1 (AT)
Inventor: LIOTTA FRANK J JR
IPC: C04B28/02
Filed: 1999-07-01
Granted: 2004-05-15
Abstract: Cementitious compositions are prepared using a dry, flowable admixture containing an ester of carbonic acid such as propylene carbonate and a solid, particulate support which is non-reactive toward the ester such as silica fume. Such admixtures accelerate the set and increase the thixotropy of unhardened mixtures containing hydraulic cement and water, yet can be readily handled and stored in stable form until ready to be used.
Patent AT-E231646-T1 (AT)
Inventor: TRABERT STEVEN G
IPC: G11B5/584
Filed: 1999-09-28
Granted: 2003-02-15
Abstract: A method of attaching a tape having longitudinal edges to a tape cartridge reel includes cutting an end of the tape non-perpendicularly to the longitudinal edges laterally across the width of the tape. The end of the tape is then attached to the tape cartridge reel. The method may also include cutting an end of the tape such that at least two of the laterally spaced apart servo stripes running longitudinally along the tape are cut at different longitudinal positions along the tape. The method may further include cutting the tape end such that at least two of the laterally spaced apart data tracks running longitudinally along the tape are cut at different longitudinal positions along the tape.
Patent AT-E254089-T1 (AT)
Inventor: SPRENGER PETER
IPC: B68B1/06
Filed: 1999-08-13
Granted: 2003-11-15
Abstract: The snaffle bit for a horse has two side rings and a shackle arranged between the two side rings. The shackle is provided with tow side portions and has at least one joint. The at least one joint defines an articulation axis. A bore is arranged in the end area of each of the side portions that is remote from the at least one joint and receives with play a respective one of the two side rings. The axes of the two bores defines a plane that is inclined at an angle of 45°±20°, preferably of 45°±10°, to the articulation axis of the at least one joint.
Patent AT-E378418-T1 (AT)
Inventor: SCHMIDT ANN
IPC: A01K67/027
Filed: 1999-10-06
Granted: 2007-11-15
Abstract: The present invention provides for an isolated human EN-RAGE peptide. The present invention also provides for a method for determining whether a compound is capable of inhibiting the interaction of an EN-RAGE peptide with a RAGE peptide, which comprises: (a) admixing: (i) a RAGE peptide or an sRAGE peptide or a fragment of either thereof, (ii) an EN-RAGE peptide or a fragment thereof, and (iii) the compound; (b) measuring the level of interaction between the peptide of step (a) (i) and the peptide of step (a) (ii), and (c) comparing the amount of interaction measured in step (b) with the amount measured between the petpide of step (a)(i) and the peptide of step (a) (ii) in the absence of the compound, thereby determining whether the compound is capable of inhibiting the interaction of the EN-RAGE peptide with the RAGE peptide, wherein a reduction in the amount of interaction in the presence of the compound indicates that the compound is capable of inhibiting the interaction. The present invention also provides for a method for inhibiting inflammation in a subject which comprises administering to the subject a compound capable of interfering with the interaction between EN-RAGE peptide and receptor for advanced glycation endproduct (RAGE) in the subject thereby inhibiting inflammation in the subject.
Patent AT-E301625-T1 (AT)
Inventor: BERGSTROEM CHRISTER
IPC: B01J23/26
Filed: 1999-12-02
Granted: 2005-08-15
Abstract: A process for producing 2,6-dimethylnapthalene from 1-(p-tolyl)-2-methylbutane, 1-(p-tolyl)-2-methylbutene or a mixture thereof by dehydrocyclization in the presence of a catalyst, comprising using non-acidic activated carbon as a catalyst.
Patent AT-E278604-T1 (AT)
Inventor: OLDE-HEUVEL BERNARDUS JOHANNES
IPC: B61H15/00
Filed: 1999-12-13
Granted: 2004-10-15
Abstract: The invention relates to a brake device for braking a movement of an object by mechanical friction, such as the movement of rails relative to a train, or the rotation of a brake disc or a cycle wheel. The brake device has a basic part with an engagement point for engagement of a braking force which can be exerted via an operator; a brake block arranged on the basic part for braking the movement of the object by friction, wherein the basic part is movable such that the brake block is movable with at least a substantial transverse component relative to the movement of the object; resetting spring means for urging the brake block away from the object to a free rest position such that in the case of a braking force smaller than the spring force a space results between the object and the brake block; a first and a second stop, which stops are arranged at a fixed mutual distance, which first stop determines the maximum distance between the object and the brake block, and which second stop adjusts itself to the contact position, i.e. the position wherein brake block and object make mutual contact, when a braking force is exerted which exceeds the spring force.
Patent AT-E292462-T1 (AT)
Inventor: BRIDGES ALEXANDER JAMES
IPC: A61K45/00
Filed: 1999-12-21
Granted: 2005-04-15
Abstract: This invention provides a method of preventing or treating asthma by administering to a patient in need of treatment an effective amount of a selective MEK inhibitor, especially a phenyl amine of Formula I and II:
Patent AT-E291590-T1 (AT)
Inventor: BARBUCCI ROLANDO
IPC: C08B15/04
Filed: 1999-11-09
Granted: 2005-04-15
Abstract: A product having application in the medical, pharmaceutical and dermo-cosmetic fields comprising a cross-linked polysaccharide in which cross-linkage exists only through amide bonds between carboxy groups of the polysaccharide and amino groupss of a polyamine.
Patent DE-04800258-T1 (DE)
Inventor: RYHMAN MORGAN
IPC: F16L37/098
Filed: 2004-11-04
Abstract: The arrangement is for coupling together two rigid tubular objects and comprises a male part and a female part (1). The female part comprises a socket, which at its one end is provided with a recess (3). The male part is tubular and at its one end has a cross edge, formed by a deepened formation in the male part outer wall. A socket-shaped component (11) is placed between the male part and the female part when the former is inserted in the latter. The socket-shaped component is provided with a spring tongue (12) with a first device (14) which on insertion of the socket-shaped component in the female component spring engages into its recess. The spring tongue allows separation of the female and male parts by rotation of the socket-shaped component relatively to the male part to a position where the spring tongue second devices are positioned radially outside the male component cross edge.
Patent DE-10084088-T1 (DE)
Inventor: BROWN KEVIN
IPC: B05D7/16
Filed: 2000-02-04
Abstract: The present invention relates to a method of treating a metal substrate to provide permanent corrosion resistance. The method comprises applying a solution containing one or more vinyl silanes in admixture with one or more multi-silyl-functional silanes to a metal substrate in order to form a coating. The method is particularly suitable for use on zinc coated surfaces.
Patent DE-11001538-T1 (DE)
Title: Methanolcarbonylierungssystem mit Absorber mit mehreren Lösungsmitteloptionen
IPC: B01D53/14
Filed: 2009-04-24
Abstract: Verbessertes Verfahren zum Betreiben einer Vorrichtung für die Herstellung von Essigsäure der Klasse, die ein Produktionssystem mit einem Reaktor, der ein Reaktionsmedium enthält, und einer Produktreinigungsstrecke aufweist, wobei das Produktionssystem zu einer Absorberkolonne entgast wird, dadurch gekennzeichnet daß: (a) Carbonylieren von Methanol oder reaktiven Derivaten davon im Reaktor in Gegenwart eines Katalysators aus einem Metall der Gruppe VIII und eines Methyliodid-Promotors, wobei eine Wasserkonzentration im Reaktor von 1 bis 10 Gew.-% des Reaktionsmediums aufrechterhalten wird und gleichzeitig ein vorbestimmter Partialdruck von Kohlenmonoxid im Reaktor beibehalten wird; (b) Ablassen von nicht-kondensierbaren Materialien aus dem Produktionssystem, so daß nur ein Abgas mit geringem Druck bereitgestellt wird; (c) Leiten des Abgases mit geringem Druck aus dem Produktionssystem zur Absorberkolonne, wobei das Abgas Methyliodid und gegebenenfalls weitere flüchtige Komponenten umfaßt; (d) Zuführen eines Lösungsmittels für die Gaswäsche zur Absorberkolonne, wobei das Lösungsmittel für die Gaswäsche Methanol, Methylacetat oder Gemische davon...
Patent DE-900142-T1 (DE)
Inventor: KELLETT RICHARD
IPC: B41M7/00
Filed: 1997-05-13
Abstract: Provided is an ink jet fluid composition which comprises a liquid carrier medium and one or more chromium complexes of organic acids. Upon ink jet printing on a printing medium and subsequent exposure to an energy source, a durable and water-insoluble layer is formed. Such an ink jet fluid composition and printing process can be advantageously used to produce durable and water-insoluble images on printing media.
Patent ES-2150403-T1 (ES)
Inventor: LAWRENCE DAVID E
IPC: B23P15/00
Filed: 1997-09-05
Abstract: A method is disclosed for manufacturing ejector sleeves from tubular stock. In particular, the method includes the following steps or operations: (a) cutting the tube stock to length, (b) enlarging a portion of the inside diameter of the sleeve to provide a clearance diameter, (c) rough-sizing a close-fitting inner diameter, (d) optionally semi-finishing the outside diameter of the sleeve, (e) hardening and straightening the sleeve, (f) final sizing of the outside diameter while maintaining concentricity with the inside diameters, (g) finishing the end face of the sleeve adjacent the close-fitting diameter, (h) final sizing of the close-fitting inner diameter while maintaining concentricity with the outside diameter, (i) forming a head on the sleeve by heating and forging to a predetermined size, (j) optional annealing and refinishing of the head for purposes of hardness or dimensional modification, or improving surface finish.
Patent CY-1107559-T1 (CY)
Title: Μικροκοκκοι θειικης μορφινης, μεθοδος παρασκευης και φαρμακευτικα σκευασματα
Inventor: DEBREGEAS PATRICE
IPC: A61K9/50
Filed: 2007-02-20
Abstract: Η παρούσα ευρεσιτεχνία αφορά νέα στοματική φόρμουλα άμεσης απελευθέρωσης θειικής μορφίνης, υπό την μορφή μικρόκοκκων. Κάθε μικρόκοκκος περιλαμβάνει ουδέτερο κόκκο υποστηρίγματος επιχρισμένο με μείγμα θειικής μορφίνης και ενός συνδετικού, όπως υδροξυπροπυλο-μεθυλοκυτταρίνης, που αντιπροσωπεύει το 10% έως 50% του βάρους του μείγματος θειική μορφίνη/συνδετικό. Η παρούσα ευρεσιτεχνία αφορά επίσης μέθοδο παρασκευής αυτών των μικρόκοκκων πραγματοποιούμενη εξ ολοκλήρου εντός υδατικού μέσου επί των ουδετέρων κόκκων υποστηρίγματος. Τέλος, η παρούσα ευρεσιτεχνία αφορά τα φαρμακευτικά σκευάσματα που περιέχουν τους σύμφωνα με την ευρεσιτεχνία μικρόκοκκους.
Patent CY-1110503-T1 (CY)
Inventor: CHOW TERRY
IPC: A61K39/395
Filed: 2009-08-11
Abstract: The present invention relates to the treatment of cancer with compounds that inhibit the activity of endo-exonuclease. Endo-exonuclease has been shown to be necessary for the repair of damaged DNA. Compounds that inhibit the activity of endo-exonuclease have been shown to be particularly effective for treating cancer when used in combination with drugs that induce DNA breaks such as cisplatin and mitomycin C. These compounds have a synergistic effect when used in combination for inhibiting tumour growth. The invention includes pharmaceutical compositions for inhibiting tumour growth comprising a compound that inhibits endo-exonuclease activity. These pharmaceutical compositions preferably include compounds that induce DNA breaks. The invention includes methods of treating cancer with these pharmaceutical compositions and uses of these compositions to treat cancer. The preferred compounds that inhibit the activity of endo-exonuclease have low toxicity. One such compound is pentamidine. The invention also includes a method for diagnosing cancer and monitoring its progression. This aspect of the invention involves isolating serum from a patient; measuring the concentration of endo-exonuclease in said serum and determining whether said concentration is above a predetermined mean.
Patent CY-1112899-T1 (CY)
Inventor: MURAKATA CHIKARA
IPC: C07D417/04
Filed: 2010-11-04
Abstract: (wherein R 1  and R 4  are the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkynyl, substituted or unsubstituted lower alkenyl, or the like; R 5  represents a substituted or unsubstituted heterocyclic group, substituted or unsubstituted aryl, or the like; R 2  represents -C(=W)R 6  or the like; R 3  represents a hydrogen atom, -C(=W A )R 6A  , or the like)  Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided.
Patent CY-1110939-T1 (CY)
Inventor: NIELSEN LARS SOEGAARD
IPC: C12N15/10
Filed: 2010-11-24
Abstract: The invention relates to a method for manufacturing a recombinant polyclonal protein composition, in particular a recombinant polyclonal antibody composition. The method comprises obtaining a collection of cells transfected with a collection of variant nucleic acid sequences, wherein each cell in the collection is transfected with and capable of expressing one member of the collection, which encodes a distinct member of a polyclonal protein. The cells are cultured under suitable conditions for expression of the polyclonal protein, which is obtained from the cells or culture supernatant. The nucleic acid sequence is introduced into the cells by transfection with a collection of vectors. The present method is suitable for manufacturing recombinant polyclonal antibodies for therapeutic uses.
Patent CY-1115120-T1 (CY)
Title: Συσκευη και μεθοδος διατρησης υπογειου φρεατος γεωτρησης
Inventor: LEUCHTENBERG CHRISTIAN
IPC: E21B21/08
Filed: 2014-01-31
Abstract: Συσκευή ελέγχου για χρήση στον έλεγχο της πίεσης του ρευστού σε γεώτρηση κατά τη διάτρηση της γεωτρήσεως, η συσκευή περιλαμβάνει είσοδο κατάλληλη για σύνδεση με αντλία, κύρια διέξοδο κατάλληλο για σύνδεση σε σωλήνα γεώτρησης, και έξοδο υπερχείλισης κατάλληλη για σύνδεση σε δεξαμενή υγρού, όπου η είσοδος συνδέεται με την κύρια έξοδο από κύριο αγωγό ροής, και η έξοδος υπερχειλίσεως συνδέεται με το κύριο αγωγό ροής μέσω ενός αγωγού υπερχείλισης, όπου ο αγωγός υπερχείλισης είναι εφοδιασμένος με ρυθμιστή πίεσης μέσω του οποίου η πίεση του ρευστού στον κύριο αγωγό της ροής μπορεί να διατηρείται σε ή γύρω από μία προκαθορισμένη τιμή πίεσης.
Patent CY-1116775-T1 (CY)
Title: Παραγωγα πυριμιδονης ως αναστολεις της ιστικης τρανσγλουταμινασης
Inventor: BÜCHOLD CHRISTIAN
IPC: A61K31/443
Filed: 2015-08-18
Abstract: Η εφεύρεση αφορά παράγωγα πυριμιδόνης του γενικού τύπου (Ι) ως αναστολείς για την ιστική τρανσγλουταμινάση, μεθόδους για την παραγωγή των παραγώγων πυριμιδόνης, φαρμακευτικές συνθέσεις που περιέχουν αυτά τα παράγωγα πυριμιδόνης, καθώς και την χρήση τους για προφύλαξη και αντιμετώπιση νόσων που σχετίζονται με την ιστική τρανσγλουταμινάση.
Patent CY-1118710-T1 (CY)
Title: Συνθεσεις για την θεραπεια της πολλαπλης σκληρυνσης
Inventor: FOUSSAT ARNAUD
IPC: C12N5/0783
Filed: 2017-03-09
Abstract: Η παρούσα εφεύρεση σχετίζεται με συνθέσεις που περιλαμβάνουν κύτταρα Tr1 που κατευθύνονται σε ένα αντιγόνο που συνδυάζεται με πολλαπλή σκλήρυνση και μεθόδους για την θεραπεία της πολλαπλής σκλήρυνσης.
Patent CY-1120648-T1 (CY)
Title: Τεχνολογια χορηγησης φαρμακου
Inventor: SAMS MARTIN JAMES
IPC: A61K47/10
Filed: 2018-08-31
Abstract: Η εφεύρεση παρέχει μια φαρμακευτική σύνθεση για τη διαβλεννική χορήγηση ενός αναστολέα PDE5, όπου η αναφερθείσα σύνθεση περιλαμβάνει έναν αναστολέα PDE5 και ένα φορέα όπου ο αναφερθείς αναστολέας PDE5 είναι διαλυτός ή σχηματίζει ένα αιώρημα ή γαλάκτωμα. Η εφεύρεση παρέχει επίσης μια φαρμακευτική σύνθεση που περιλαμβάνει έναν αναστολέα PDE5 για χρήση στην αναστολή της δράσης του PDE in vivo, όπου στην αναφερθείσα χρήση η αναφερθείσα σύνθεση χορηγείται μέσω της διαβλεννικής οδού.
Patent CY-1121013-T1 (CY)
Title: Μεθοδος για την παραγωγη δεσμης ακτινοβολιας στην περιοχη του υπερυθρου
Inventor: VAN HATTUM EDGAR JOHANNES
IPC: H05B3/14
Filed: 2018-12-12
Abstract: Η μέθοδος αφορά την παραγωγή δέσμης ακτινοβολίας στην περιοχή του υπερύθρου. Μια πηγή ακτινοβολίας τροφοδοτείται ηλεκτρικά και μετατρέπει την ηλεκτρική ενέργεια τροφοδοσίας, τουλάχιστον εν μέρει, στην υπέρυθρη ακτινοβολία. Η εν λόγω πηγή ακτινοβολίας περιλαμβάνει τουλάχιστον μια ίνα από συνθετικό υλικό. Η ίνα έχει ηλεκτρική αγωγιμότητα. Το υλικό της ίνας παρασκευάζεται βάσει ενός κύριου κατασκευαστικού υλικού από PET. Στο κύριο κατασκευαστικό υλικό είναι ενσωματωμένα διάφορα στοιχεία. Τα στοιχεία αυτά έχουν ατομικές διαστάσεις και τα ηλεκτρονιακά νέφη αυτών αλληλεπικαλύπτονται τουλάχιστον σε ορισμένες περιοχές.
Patent CY-1123040-T1 (CY)
Title: Συνθεση με βαση αμινοξεα για την αποκατασταση ινο-ελαστινης σε δερματικους συνδετικους ιστους
Inventor: GIORGETTI PAOLO
IPC: A61K31/198
Filed: 2020-04-06
Abstract: Η παρούσα εφεύρεση αφορά συνθέσεις οι οποίες περιέχουν ως δραστικό συστατικό ένα μίγμα αμινοξέων ικανό να διεγείρει τη βιοσύνθεση ελαστίνης και κολλαγόνου.